Jade Biosciences, Inc.
JBIO
$7.42
$0.0150.20%
NASDAQ
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Net Income | -38.17M | ||||
| Total Depreciation and Amortization | 8.00K | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | 17.82M | ||||
| Change in Net Operating Assets | 1.58M | ||||
| Cash from Operations | -18.76M | ||||
| Capital Expenditure | -- | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -- | ||||
| Cash from Investing | -- | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -700.00K | ||||
| Cash from Financing | -700.00K | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -19.46M | ||||